The timing of influenza vaccination for older adults (65 years and older)

Bruce Y. Lee; Julie H.Y. Tai; Rachel R. Bailey; Kenneth J. Smith

doi:10.1016/j.vaccine.2009.09.056

The timing of influenza vaccination for older adults (65 years and older)

Bruce Y. Lee, Julie H.Y. Tai, Rachel R. Bailey, Kenneth J. Smith

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

While studies have found influenza vaccination to be cost-effective in older adults (65 years or older), they have not looked at how the vaccine's economic value may vary with the timing of vaccine administration. We developed a set of computer simulation models to evaluate the economic impact of vaccinating older adults at different months. Our models delineated the costs and utility losses in delaying vaccination past October and suggest that policy makers and payors may consider structuring incentives (≤$2.50 per patient) to vaccinate in October. Our results also suggest that vaccination is still cost-effective through the end of February.

Original language	English (US)
Pages (from-to)	7110-7115
Number of pages	6
Journal	Vaccine
Volume	27
Issue number	50
DOIs	https://doi.org/10.1016/j.vaccine.2009.09.056
State	Published - Nov 23 2009
Externally published	Yes

Keywords

Computer simulation
Economics
Influenza vaccine
Older adults
Vaccine administration

ASJC Scopus subject areas

Molecular Medicine
General Immunology and Microbiology
General Veterinary
Public Health, Environmental and Occupational Health
Infectious Diseases

Access to Document

10.1016/j.vaccine.2009.09.056

Cite this

@article{9ffc5a4f76fa40209c06b86dc8fe1f30,

title = "The timing of influenza vaccination for older adults (65 years and older)",

abstract = "While studies have found influenza vaccination to be cost-effective in older adults (65 years or older), they have not looked at how the vaccine's economic value may vary with the timing of vaccine administration. We developed a set of computer simulation models to evaluate the economic impact of vaccinating older adults at different months. Our models delineated the costs and utility losses in delaying vaccination past October and suggest that policy makers and payors may consider structuring incentives (≤$2.50 per patient) to vaccinate in October. Our results also suggest that vaccination is still cost-effective through the end of February.",

keywords = "Computer simulation, Economics, Influenza vaccine, Older adults, Vaccine administration",

author = "Lee, {Bruce Y.} and Tai, {Julie H.Y.} and Bailey, {Rachel R.} and Smith, {Kenneth J.}",

note = "Funding Information: This study was supported by the National Institute General Medical Sciences Models of Infectious Agent Study (MIDAS) grant U01-GM070708-05. ",

year = "2009",

month = nov,

day = "23",

doi = "10.1016/j.vaccine.2009.09.056",

language = "English (US)",

volume = "27",

pages = "7110--7115",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier BV",

number = "50",

}

TY - JOUR

T1 - The timing of influenza vaccination for older adults (65 years and older)

AU - Lee, Bruce Y.

AU - Tai, Julie H.Y.

AU - Bailey, Rachel R.

AU - Smith, Kenneth J.

N1 - Funding Information: This study was supported by the National Institute General Medical Sciences Models of Infectious Agent Study (MIDAS) grant U01-GM070708-05.

PY - 2009/11/23

Y1 - 2009/11/23

N2 - While studies have found influenza vaccination to be cost-effective in older adults (65 years or older), they have not looked at how the vaccine's economic value may vary with the timing of vaccine administration. We developed a set of computer simulation models to evaluate the economic impact of vaccinating older adults at different months. Our models delineated the costs and utility losses in delaying vaccination past October and suggest that policy makers and payors may consider structuring incentives (≤$2.50 per patient) to vaccinate in October. Our results also suggest that vaccination is still cost-effective through the end of February.

AB - While studies have found influenza vaccination to be cost-effective in older adults (65 years or older), they have not looked at how the vaccine's economic value may vary with the timing of vaccine administration. We developed a set of computer simulation models to evaluate the economic impact of vaccinating older adults at different months. Our models delineated the costs and utility losses in delaying vaccination past October and suggest that policy makers and payors may consider structuring incentives (≤$2.50 per patient) to vaccinate in October. Our results also suggest that vaccination is still cost-effective through the end of February.

KW - Computer simulation

KW - Economics

KW - Influenza vaccine

KW - Older adults

KW - Vaccine administration

UR - http://www.scopus.com/inward/record.url?scp=70350572339&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70350572339&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2009.09.056

DO - 10.1016/j.vaccine.2009.09.056

M3 - Article

C2 - 19786135

AN - SCOPUS:70350572339

SN - 0264-410X

VL - 27

SP - 7110

EP - 7115

JO - Vaccine

JF - Vaccine

IS - 50

ER -

The timing of influenza vaccination for older adults (65 years and older)

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this